February 2023 - Page 15 of 18

MondayFeb 06, 2023 2:00 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Animal Study Results Featured in Aegis Capital Corp. Updated Price Target

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, is the subject of an updated report released from Aegis Capital Corp. The update reflects the strong results from BVXV’s latest animal study indicating that anti-COVID-19 NanoAb can prevent infection. According to the report, BiondVax reported that in a continuation of the study, COVID-19 illness was virtually prevented in hamsters that received BiondVax’s inhaled NanoAb and infected three hours later with SARS-CoV-2. The report noted that data gathered from the preclinical trial show that BiondVax’s…

MondayFeb 06, 2023 12:26 pm

QualityStocksNewsBreaks – Coyuchi Inc. Driving Growth While Focusing on Positive Environmental, Social Impacts

Coyuchi, the first organic luxury home goods brand for sustainable living, in August 2022 announced its first public offering under Regulation A+ authorization. “This round of funding will be used to grow Coyuchi’s leadership through expanded marketing, product category expansion, continued physical presence, and B2B strategic partnerships with wholesalers and online marketplaces. The company has now exceeded $1 million in capital raising with the unique investment opportunity handled by Manhattan Street Capital. Funds raised during the beginning of the Regulation A+ offering have allowed Coyuchi to open a second retail location in the Palo Alto Town & Country Village… During…

MondayFeb 06, 2023 12:00 pm

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announces Successful Capital Raising; Net Proceeds Will Be Destined Towards Ongoing Bolivian Mining Operations

Eloro Resources announced the successful completion of its primary share issuance in late January, 2023 The placement, which comprised of over 3.4 million primary shares issued at a price of c$3.15, raised gross proceeds of approximately C$10.9mn The proceeds will be destined to Eloro’s ongoing Bolivian mining operations as well as general corporate purposes Eloro Resources is set to disclose its initial resource estimates for its flagship Iska Iska Project in coming months Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec,…

MondayFeb 06, 2023 11:15 am

MetAlert, Inc. (MLRT) – Developing New and Practical GPS Tracking and Other Health Tech Solutions for Real-World Caregivers and Businesses

MetAlert, a developer of personal protective medical equipment and supplies, owes much of its growth to acting on feedback from real-world caregivers who use its products for the monitoring and tracking of vulnerable patients This connection with caregivers has yielded advanced products such as the award-winning, multi-patented GPS SmartSole, Invisabelt, Take-Along Tracker, and Rover Tracker, among others Attention to consumers has also led to its line of hearing aids, such as its flagship Hear IQ 4 rechargeable, app-controlled hearing aid, and its RoomMate wall-mounted 3D sensors for looking after patients without intruding on their personal space MetAlert (OTC: MLRT), a…

MondayFeb 06, 2023 10:42 am

QualityStocksNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Wins Largest Commercial Lidar Deployment Contract in Tolling Sector to Date

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has been awarded a multimillion sales contract from one of the leading U.S. highway tolling systems in the country. The company announced that its exclusive, state-of-the-art lidar solution will be deployed nationwide; the contract is designed to improve and enable accurate and intelligent tolling applications. According to the announcement, the large-scale contract calls for CPTN’s Sora series lidar sensors to be positioned on several major tollways located in the Tri-State area and Northern California in what is projected to be the largest commercial lidar deployment in the tolling…

MondayFeb 06, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Aiming to Capture Significant Market Share for Treatment and Prevention of COVID-19 Illness with Innovative Inhaled NanoAb

BiondVax is a biotechnology company3` focused on developing, manufacturing, and commercializing innovative immunotherapeutic products The company is developing nanosized antibodies (“NanoAbs”) addressing large market diseases underserved by current treatments, with its lead candidate targeting COVID-19 The FDA recently revoked the sole authorization of a COVID prophylactic, Evusheld, citing the inability of the monoclonal antibody cocktail to neutralize emerging subvariants of the Omicron variant BiondVax’s lead NanoAb candidate shows superior advantages to monoclonal antibodies, with the data gathered strengthening the value proposition of the COVID-19 NanoAb as a safe, efficacious, and convenient therapeutic and prophylactic drug The Food and Drug Administration…

MondayFeb 06, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) To Intensify Focus on Commercial Execution of its DehydraTECH Technology for the 2023 Calendar year

2022 saw Lexaria introduce its patented DehydraTECH(TM) technology to world-leading collaborators while also exploring DehydraTECH-CBD for the potential treatment of hypertension It also saw success in its research for the potential treatment of conditions such as epilepsy, making the year Lexaria’s most active one yet Significant progress was made on key objectives in 2022, a feat which the company plans to capitalize on and leverage to scale up the commercial execution of its technology in 2023 To facilitate this, Lexaria has brought on board Julian Gangolli, former President of GW Pharmaceuticals USA, as a strategic advisor. Chris Bunka, Lexaria’s CEO,…

FridayFeb 03, 2023 1:26 pm

QualityStocksNewsBreaks – CubCrafters Inc.’s Long Relationship with US Government Demonstrates Its Exceptional Abilities in Backcountry Aviation

CubCrafters is the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft. “For close to two decades now, CubCrafters has supplied aircraft to various U.S. Federal Government agencies, including the U.S. Air Force Research Laboratory, the U.S. Air Force Flight Academy, the U.S. Department of Agriculture (‘USDA’), the U.S. Department of Homeland Security (‘DHS’), and the U.S. Department of the Interior (‘DOI’)… The consistent appeal of CubCrafters’ aircraft stems from the fact that they have significantly lower operational costs compared to helicopters and other more expensive fixed-wing aircraft… In addition to the lower operational cost, CubCrafters…

FridayFeb 03, 2023 1:03 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Helping Companies to Affordably Transition from Dependence on Carbon Fuel

Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled distributed energy solutions company, foresees exciting new opportunities available thanks to the government’s emphasis on driving the country toward a future free of its dependence on carbon fuel and otherwise inefficient utilities. “Correlate is focused on helping companies that develop and rent out commercial building properties succeed at acquiring solar, cogeneration, energy storage, and electric vehicle infrastructure, and doing so in a way that is both affordable and profit-improving for the client,” a recent article reads. “The company’s subsidiaries work harmoniously to analyze clients’ utilities performance. Correlate then provides recommendations for improvements based…

FridayFeb 03, 2023 12:33 pm

QualityStocksNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Distinctive Solutions Positioned to Transform the Way Patients, Doctors Detect Heart Attacks

HeartBeam (NASDAQ: BEAT) is a cardiac technology company that is leading the way in identifying heart attacks by developing a personal, portable and easy-to-use heart-attack detection solution. “The company has two patented products in development: HeartBeam AIMI(TM), software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack, and HeartBeam AIMIGo(TM), the first and only credit-card-sized 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system to facilitate remote heart-attack detection… The company anticipates receiving regulatory approval soon for the use of the HeartBeam…

Site Search

Company Search

Month: February 2023